Boule Diagnostics AB Stock OTC Markets
Stocks
BDAB.F
SE0011231158
Advanced Medical Equipment & Technology
OTC Markets Traded
| Market Cap | 134M 13.82M 12.14M 11.19M 10.48M 19.63M 1.31B 19.96M 52.01M 643M 51.89M 50.78M 2.23B | P/E 2026 * |
-13.7x | P/E 2027 * | 15.6x |
|---|---|---|---|---|---|
| Enterprise Value | 331M 34.04M 29.91M 27.56M 25.8M 48.34M 3.23B 49.15M 128M 1.58B 128M 125M 5.5B | EV / Sales 2026 * |
0.73x | EV / Sales 2027 * | 0.66x |
| Free-Float |
50.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boule Diagnostics AB
| 1 day | -55.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Folkunger
CEO | Chief Executive Officer | - | 2026-06-21 |
Torben Nielsen
CEO | Chief Executive Officer | - | 2024-04-15 |
| Director of Finance/CFO | 54 | 2026-02-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 2013-12-31 | |
| Chairman | 73 | 2020-12-31 | |
| Chairman | 74 | 2022-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -55.23% | -89.53% | - | - | 13.63M | |
| +1.15% | -0.69% | +17.28% | -10.47% | 172B | |
| +0.06% | -3.33% | -21.73% | +23.20% | 143B | |
| +0.44% | -1.31% | -8.85% | -24.86% | 126B | |
| +2.86% | -2.81% | -55.45% | -15.51% | 65.89B | |
| +1.25% | -1.84% | +15.44% | -3.75% | 49.45B | |
| +0.06% | -1.26% | -25.33% | -31.86% | 44.05B | |
| +0.14% | -1.30% | +9.08% | +6.07% | 35.72B | |
| -0.29% | -0.93% | +4.19% | +37.47% | 35.18B | |
| +5.08% | +0.77% | -10.46% | -20.17% | 27.58B | |
| Average | -4.65% | -2.49% | -8.43% | -4.43% | 77.68B | |
| Weighted average by Cap. | +0.58% | -2.43% | -7.24% | -4.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 453M 46.62M 40.95M 37.74M 35.33M 66.19M 4.42B 67.3M 175M 2.17B 175M 171M 7.53B | 483M 49.73M 43.68M 40.25M 37.68M 70.6M 4.71B 71.79M 187M 2.31B 187M 183M 8.03B |
| Net income | -9.77M -1.01M -883K -814K -762K -1.43M -95.25M -1.45M -3.78M -46.73M -3.77M -3.69M -162M | 8.6M 884K 777K 716K 670K 1.26M 83.78M 1.28M 3.33M 41.11M 3.32M 3.25M 143M |
| Net Debt | 197M 20.22M 17.76M 16.37M 15.32M 28.71M 1.92B 29.19M 76.08M 940M 75.91M 74.28M 3.27B | 185M 18.98M 16.68M 15.37M 14.39M 26.95M 1.8B 27.41M 71.43M 882M 71.26M 69.73M 3.07B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
